Optimization of MR imaging for pretreatment evaluation of patients with endometrial and cervical cancer

Radiographics

Volumn 34, Issue 4, 2014, Pages 1082-1098

  Rauch, Gaiane M ^a   Kaur, Harmeet ^a   Choi, Haesun ^a   Ernst, Randy D ^a   Klopp, Ann H ^b   Boonsirikamchai, Piyaporn ^a   Westin, Shannon N ^c   Marcal, Leonardo P ^a  

^a From the Department of Diagnostic Radiology   (United States)

^b Department of Radiation Oncology ^*  (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOMETRIAL NEOPLASMS; FEMALE; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROCEDURES; STANDARDS; UTERINE CERVICAL NEOPLASMS;

ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; UTERINE CERVICAL NEOPLASMS;

EID: 84904370009     PISSN: 02715333     EISSN: 15271323     Source Type: Journal    
DOI: 10.1148/rg.344140001     Document Type: Article

References (54)

1. Howlader N, Noone A, Krapcho M, et al. SEER Cancer Statistics Review (CSR), 1975-2010. National Cancer Institute [serial online]. http://seer.cancer.gov/csr/1975_2010/. Published 2012. Accessed April 8, 2013.
2. Sala E, Wakely S, Senior E, Lomas D. MRI of malignant neoplasms of the uterine corpus and cervix. AJR Am J Roentgenol 2007;188(6):1577-1587.
3. Lewin SN. Revised FIGO staging system for endometrial cancer. Clin Obstet Gynecol 2011;54(2): 215-218.
4. Sala E, Rockall A, Kubik-Huch RA. Advances in magnetic resonance imaging of endometrial cancer. Eur Radiol 2011;21(3):468-473.
5. Larson DM, Connor GP, Broste SK, Krawisz BR, Johnson KK. Prognostic significance of gross myometrial invasion with endometrial cancer. Obstet Gynecol 1996;88(3):394-398.
6. Todo Y, Kato H, Kaneuchi M, Watari H, Takeda M, Sakuragi N. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet 2010;375 (9721):1165-1172.
7. Freeman SJ, Aly AM, Kataoka MY, Addley HC, Reinhold C, Sala E. The revised FIGO staging system for uterine malignancies: implications for MR imaging. RadioGraphics 2012;32(6):1805-1827.
8. Frei KA, Kinkel K. Staging endometrial cancer: role of magnetic resonance imaging. J Magn Reson Imaging 2001;13(6):850-855.
9. Manfredi R, Gui B, Maresca G, Fanfani F, Bonomo L. Endometrial cancer: magnetic resonance imaging. Abdom Imaging 2005;30(5): 626-636.
10. Sanjuán A, Escaramís G, Ayuso JR, et al. Role of magnetic resonance imaging and cause of pitfalls in detecting myometrial invasion and cervical involvement in endometrial cancer. Arch Gynecol Obstet 2008;278(6):535-539.
11. Cade TJ, Quinn MA, McNally OM, Neesham D, Pyman J, Dobrotwir A. Predictive value of magnetic resonance imaging in assessing myometrial invasion in endometrial cancer: is radiological staging sufficient for planning conservative treatment? Int J Gynecol Cancer 2010;20(7):1166-1169.
12. Querleu D, Planchamp F, Narducci F, et al. Clinical practice guidelines for the management of patients with endometrial cancer in France: recommendations of the Institut National du Cancer and the Société Française d'Oncologie Gynécologique. Int J Gynecol Cancer 2011;21(5):945-950.
13. Kinkel K, Forstner R, Danza FM, et al. Staging of endometrial cancer with MRI: guidelines of the European Society of Urogenital Imaging. Eur Radiol 2009;19(7):1565-1574.
14. Husband JE, Padhani AR, Royal College of Radiologists. Recommendations for cross-sectional imaging in cancer management. London, England: Royal College of Radiologists, 2006.
15. Frei KA, Kinkel K, Bonél HM, Lu Y, Zaloudek C, Hricak H. Prediction of deep myometrial invasion in patients with endometrial cancer: clinical utility of contrast-enhanced MR imaging-a metaanalysis and Bayesian analysis. Radiology 2000; 216(2):444-449.
16. Benedetti Panici P, Basile S, Maneschi F, et al. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 2008; 100(23):1707-1716.
17. Berman ML, Ballon SC, Lagasse LD, Watring WG. Prognosis and treatment of endometrial cancer. Am J Obstet Gynecol 1980;136(5):679-688.
18. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer: A Gynecologic Oncology Group Study. Cancer 1987;60(8 Suppl):2035-2041.
19. Beddy P, O'Neill AC, Yamamoto AK, Addley HC, Reinhold C, Sala E. FIGO staging system for endometrial cancer: added benefits of MR imaging. RadioGraphics 2012;32(1):241-254.
20. Balleyguier C, Sala E, Da Cunha T, et al. Staging of uterine cervical cancer with MRI: guidelines of the European Society of Urogenital Radiology. Eur Radiol 2011;21(5):1102-1110.
21. Van Nagell JR Jr, Roddick JW Jr, Lowin DM. The staging of cervical cancer: inevitable discrepancies between clinical staging and pathologic findinges. Am J Obstet Gynecol 1971;110(7):973-978.
22. Hricak H, Gatsonis C, Chi DS, et al. Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183. J Clin Oncol 2005;23(36):9329-9337.
23. Hricak H, Gatsonis C, Coakley FV, et al. Early invasive cervical cancer: CT and MR imaging in preoperative evaluation-ACRIN/GOG comparative study of diagnostic performance and interobserver variability. Radiology 2007;245(2):491-498.
24. Stenstedt K, Hellström AC, Fridsten S, Blomqvist L. Impact of MRI in the management and staging of cancer of the uterine cervix. Acta Oncol 2011;50 (3):420-426.
25. Kamimori T, Sakamoto K, Fujiwara K, et al. Parametrial involvement in FIGO stage IB1 cervical carcinoma diagnostic impact of tumor diameter in preoperative magnetic resonance imaging. Int J Gynecol Cancer 2011;21(2):349-354.
26. Ferrandina G, Petrillo M, Restaino G, et al. Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? Cancer 2012;118(2):392-403.
27. Sala E, Rockall AG, Freeman SJ, Mitchell DG, Reinhold C. The added role of MR imaging in treatment stratification of patients with gynecologic malignancies: what the radiologist needs to know. Radiology 2013;266(3):717-740.
28. Bhosale P, Peungjesada S, Devine C, Balachandran A, Iyer R. Role of magnetic resonance imaging as an adjunct to clinical staging in cervical carcinoma. J Comput Assist Tomogr 2010;34(6):855-864.
29. Sala E, Crawford R, Senior E, et al. Added value of dynamic contrast-enhanced magnetic resonance imaging in predicting advanced stage disease in patients with endometrial carcinoma. Int J Gynecol Cancer 2009;19(1):141-146.
30. Chung HH, Kang SB, Cho JY, et al. Accuracy of MR imaging for the prediction of myometrial invasion of endometrial carcinoma. Gynecol Oncol 2007;104(3):654-659.
31. Rockall AG, Meroni R, Sohaib SA, et al. Evaluation of endometrial carcinoma on magnetic resonance imaging. Int J Gynecol Cancer 2007;17 (1):188-196.
32. Lin G, Ng KK, Chang CJ, et al. Myometrial invasion in endometrial cancer: diagnostic accuracy of diffusion-weighted 3.0-T MR imaging-initial experience. Radiology 2009;250(3):784-792.
33. Sala E, Rockall A, Rangarajan D, Kubik-Huch RA. The role of dynamic contrast-enhanced and diffusion weighted magnetic resonance imaging in the female pelvis. Eur J Radiol 2010;76(3):367-385.
34. Beddy P, Moyle P, Kataoka M, et al. Evaluation of depth of myometrial invasion and overall staging in endometrial cancer: comparison of diffusionweighted and dynamic contrast-enhanced MR imaging. Radiology 2012;262(2):530-537.
35. Lee EJ, Byun JY, Kim BS, Koong SE, Shinn KS. Staging of early endometrial carcinoma: assessment with T2-weighted and gadolinium-enhanced T1-weighted MR imaging. RadioGraphics 1999;19 (4):937-945; discussion 946-947.
36. Levy A, Medjhoul A, Caramella C, et al. Interest of diffusion-weighted echo-planar MR imaging and apparent diffusion coefficient mapping in gynecological malignancies: a review. J Magn Reson Imaging 2011;33(5):1020-1027.
37. Punwani S. Diffusion weighted imaging of female pelvic cancers: concepts and clinical applications. Eur J Radiol 2011;78(1):21-29.
38. Whittaker CS, Coady A, Culver L, Rustin G, Padwick M, Padhani AR. Diffusion-weighted MR imaging of female pelvic tumors: a pictorial review. RadioGraphics 2009;29(3):759-774; discussion 774-778.
39. Namimoto T, Awai K, Nakaura T, Yanaga Y, Hirai T, Yamashita Y. Role of diffusion-weighted imaging in the diagnosis of gynecological diseases. Eur Radiol 2009;19(3):745-760.
40. Fujii S, Matsusue E, Kigawa J, et al. Diagnostic accuracy of the apparent diffusion coefficient in differentiating benign from malignant uterine endometrial cavity lesions: initial results. Eur Radiol 2008;18(2):384-389.
41. Tamai K, Koyama T, Saga T, et al. Diffusionweighted MR imaging of uterine endometrial cancer. J Magn Reson Imaging 2007;26(3):682-687.
42. Sheu MH, Chang CY, Wang JH, Yen MS. Preoperative staging of cervical carcinoma with MR imaging: a reappraisal of diagnostic accuracy and pitfalls. Eur Radiol 2001;11(9):1828-1833.
43. Wagenaar HC, Trimbos JB, Postema S, et al. Tumor diameter and volume assessed by magnetic resonance imaging in the prediction of outcome for invasive cervical cancer. Gynecol Oncol 2001;82 (3):474-482.
44. Shiraiwa M, Joja I, Asakawa T, et al. Cervical carcinoma: efficacy of thin-section oblique axial T2-weighted images for evaluating parametrial invasion. Abdom Imaging 1999;24(5):514-519.
45. Hawighorst H, Knapstein PG, Weikel W, et al. Cervical carcinoma: comparison of standard and pharmacokinetic MR imaging. Radiology 1996;201(2): 531-539.
46. Chen J, Zhang Y, Liang B, Yang Z. The utility of diffusion-weighted MR imaging in cervical cancer. Eur J Radiol 2010;74(3):e101-e106.
47. Naganawa S, Sato C, Kumada H, Ishigaki T, Miura S, Takizawa O. Apparent diffusion coefficient in cervical cancer of the uterus: comparison with the normal uterine cervix. Eur Radiol 2005;15(1):71-78.
48. Nicolet V, Carignan L, Bourdon F, Prosmanne O. MR imaging of cervical carcinoma: a practical staging approach. RadioGraphics 2000;20(6):1539-1549.
49. Liu Y, Liu H, Bai X, et al. Differentiation of metastatic from non-metastatic lymph nodes in patients with uterine cervical cancer using diffusion-weighted imaging. Gynecol Oncol 2011;122(1):19-24.
50. Choi HJ, Kim SH, Seo SS, et al. MRI for pretreatment lymph node staging in uterine cervical cancer. AJR Am J Roentgenol 2006;187(5):W538-W543.
51. Lin G, Ho KC, Wang JJ, et al. Detection of lymph node metastasis in cervical and uterine cancers by diffusion-weighted magnetic resonance imaging at 3T. J Magn Reson Imaging 2008;28(1):128-135.
52. Kitajima K, Suzuki K, Senda M, et al. Preoperative nodal staging of uterine cancer: is contrastenhanced PET/CT more accurate than non-enhanced PET/CT or enhanced CT alone? Ann Nucl Med 2011;25(7):511-519.
53. Reinhardt MJ, Ehritt-Braun C, Vogelgesang D, et al. Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET. Radiology 2001;218(3):776-782.
54. Kaur H, Choi H, You YN, et al. MR imaging for preoperative evaluation of primary rectal cancer: practical considerations. RadioGraphics 2012;32 (2):389-409.